Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

WuXi AppTec Reports Solid First-Quarter 2020 Results

SHANGHAI, April 29, 2020 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 2359.HK), a company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and del...

2020-04-29 17:30 9121

VUNO Med® LungCT AI™ Receives MFDS Regulatory Approval

SEOUL, South Korea, April 28, 2020 /PRNewswire/ -- VUNO, a member company of the Born2Global Centre, announced that the first CT based pulmonary nodule detecting AI solution in Korea, "VUNO Med®-LungCT AI™", was approved by the Ministry of Food and Drug Safety. The AI solution that effectively de...

2020-04-29 14:25 1148

VUNO Med® LungCT AI™ Receives MFDS Regulatory Approval

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

WAVRE, Belgium, April 29, 2020 /PRNewswire/ -- iSTAR Medical SA , a clinical-stage medical device company pioneering truly biocompatible solutions for glaucoma, today announced positive results from two clinical trials of its micro-invasive glaucoma surgery (MIGS) impla...

2020-04-29 14:00 1022

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

Gracell Reports Data of First-in-human Clinical Trial for Universal TruUCAR™ GC027 in Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Virtual Annual Meeting

SUZHOU, China and SHANGHAI, April 28, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, has announced data of its first-in-human clinical trial for UniversalTruUCAR™ GC027 in relapsed or refractory (R/R) T-cell acute lympho...

2020-04-29 04:00 1355

United Imaging Ships 8,500th System

HOUSTON, April 28, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, confirmed it shipped its 8,500th system worldwide,a uMI 550 digital PET/CT destined for The University of Texas Health Science Center at Houston (UTHealth), near United ...

2020-04-28 20:00 1166

German Bundesliga Measures Temperature: DERMALOG Fever Detection at Bayer 04 Leverkusen

Despite the void in the world's major sports arenas, #StayHome is only possible in a limited way for many top athletes. Sports clubs are seeking solutions to ensure training with a high level of health protection. The German Bundesliga soccer team Bayer 04 Leverkusen uses DERMALOG's fever detecti...

2020-04-28 18:53 1454

Amcor to report Third Quarter 2020 Year to Date Results

ZURICH, April 27, 2020 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its year to date results for the nine months ended31 March 2020 after the US market closes at4.00 pm US Eastern Daylight Time on Monday 11 May 2020 / 6.00 am Australian Eastern Standard Time on Tuesday 12 May 20...

2020-04-28 07:00 8070

USANA steps up to help those in need around the world during the COVID-19 pandemic

SALT LAKE CITY, April 27, 2020 /PRNewswire/ -- Strong global corporate citizens step up to do their part when the world is hurting and in need. It's why USANA, theUSANA Foundation, and several of its international markets have answered the call to provide significant donations during the COVID-19...

2020-04-27 23:18 4803

CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma

SHANGHAI, April 27, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion on CARsgen's application for orphan designation of its...

2020-04-27 18:00 5367

Hebron Technology Co., Ltd. Reports Fiscal Year 2019 Financial Results

WENZHOU, China, April 24, 2020 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a technology oriented enterprise group conducting business in the pharmaceutical equipment and engineering industry segment and financial service industry segment, today announce...

2020-04-25 05:00 10601

Taiwan Textile Industry Actively Helping the United States and Global Partners to Combat COVID-19 Pandemic

TAIPEI, April 23, 2020 /PRNewswire/ -- Taiwan Textile Federation (TTF), by integrating upstream, midstream, and downstream textile industries and with the help of textile manufacturers such as Formosa Plastic Group, Formosa Chemicals & Fibre Corporation, Far Eastern New Century Corporation, KNH E...

2020-04-23 19:00 2552

Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics Inc. announced the successful FDA IND approval of IMC-002 under a development and manufacturing agreement with Samsung Biologics since 2018. As a result, ImmuneOncia will begin Phase 1 ...

2020-04-23 08:00 1468

Xi'an Launches Anti-pandemic Cooperation with Her International Sister Cities

XI'AN, China, April 22, 2020 /PRNewswire/ -- On April 10, a special video conference took place in the ancient city ofXi'an in northwest China, according to Xi'an Municipal Government. An expert team comprised of professors from the First Affiliated Hospital of Xi'an Jiaotong University shared ex...

2020-04-22 21:30 1187

Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma

SYDNEY, April 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for67Cu-SARTATE™, a therapy for the clinica...

2020-04-21 21:13 1177

World's first face mask made from coffee - an eco-friendly message from AirX

HO CHI MINH CITY, Vietnam, April 21, 2020 /PRNewswire/ -- The disposal of face masks and medical waste during the COVID-19 pandemic is putting increasing pressure on the environment. According to statistics during the COVID-19 pandemic inMainland China, 116 million tons of masks were consumed eve...

2020-04-21 20:14 2709

Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001

SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou) Co., Lim...

2020-04-20 23:00 1107

Vela Diagnostics receives BARDA funding to develop COVID-19 tests

FAIRFIELD, N.J., April 20, 2020 /PRNewswire/ -- Vela Diagnostics has been awarded a$225,000 contract by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Service...

2020-04-20 21:00 1389

Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries

SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for a significant portion of globally performed ...

2020-04-20 20:00 1795

EDAN to Dispatch Thousands of Medical Devices to NHS Nightingale

SHENZHEN, China, April 20, 2020 /PRNewswire/ -- To ease the strain on medical equipment, EDAN cooperates with the National Health Service (NHS) to install thousands of patient monitors in hospitals in theUnited Kingdom, including Britain's first coronavirus field hospital NHS Nightingale. Other t...

2020-04-20 16:12 1448

EDAN to Dispatch Thousands of Medical Devices to NHS Nightingale

Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma

SUZHOU, China, April 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 1801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major dis...

2020-04-20 08:00 2287

1 ... 201 202 203204205 206 207 ... 213